跳至主要内容
临床试验/CTRI/2010/091/002958
CTRI/2010/091/002958已完成4 期

Assessment of Quality of life in postmenopausal women with osteoporosis using salmon calcitonin nasal spray.

Glenmark Pharmaceuticals Ltd0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Pms

入排标准

入选标准

  • a.Postmenopausal women between 45-65 years of age or surgical menopausal (oophorectomy) cases
  • b.Bone mineral density(BMD) values -2.5 SD in at least one region measured by Dual Energy X-ray absorptiometry (DEXA)

排除标准

  • a.Presence of secondary causes of osteoporosis and other possible causes of back pain (fragility fracture ,bone metastasis or inflammatory spine disease such as spondylarthritis)
  • b.Use of medications that cause osteoporosis
  • c.Any contraindications for using salmon calcitonin or calcium
  • d.History of taking anti osteoporotic agents in the last month

研究者

发起方
Glenmark Pharmaceuticals Ltd

相似试验